Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile

Silvio Danese, Stefanos Bonovas, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)767-768
Number of pages2
JournalJournal of Crohn's & colitis
Volume11
Issue number7
DOIs
Publication statusPublished - Jul 1 2017

Keywords

  • Journal Article

Cite this